This article synthesizes current research on the critical disparity between cultured and total bacterial diversity revealed by high-throughput sequencing (HTS).
Oligotrophic bacteria, adapted to low-nutrient environments, pose significant challenges for cultivation and detection in pharmaceutical quality control and drug development.
This article comprehensively reviews the physiological basis for the induction of the viable but non-culturable (VBNC) state, a dormant survival strategy employed by bacteria under stress.
This article provides a comprehensive overview of modern high-throughput (HT) culturing techniques specifically designed to isolate and study bacteria under various stress conditions.
Mature biofilms present a formidable challenge in treating persistent infections due to their dense extracellular matrix that severely limits the penetration and efficacy of conventional antimicrobials.
This article provides a comprehensive evaluation of CRISPR-based diagnostic technologies against traditional culture methods for detecting pathogens within biofilms.
The escalating global health crisis of antimicrobial resistance (AMR) is profoundly fueled by biofilm-associated infections, which confer immense tolerance to conventional antibiotics.
This article provides a comprehensive resource for researchers and drug development professionals on designing effective CRISPR-Cas9 guide RNAs (gRNAs) to combat biofilm-mediated antibiotic resistance.
The application of CRISPR-Cas systems for biofilm eradication represents a paradigm shift from broad-spectrum antimicrobials to precision genetic warfare.
The escalating crisis of antibiotic-resistant biofilm-associated infections demands innovative therapeutic strategies.